Found: 293
Select item for more details and to access through your institution.
Cefazolin-Associated INR Elevation: A Case Report.
- Published in:
- Journal of Pharmacy Practice, 2024, v. 37, n. 1, p. 234, doi. 10.1177/08971900221132680
- By:
- Publication type:
- Article
Variation Among Infectious Diseases Pharmacists for the Treatment of Staphylococcus aureus Bacteremia.
- Published in:
- Journal of Pharmacy Practice, 2023, v. 36, n. 2, p. 295, doi. 10.1177/08971900211038864
- By:
- Publication type:
- Article
Patient Case Report Daptomycin Holiday—A Daptomycin Dosing Strategy for Asymptomatic Increases in Creatine Phosphokinase Levels.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Performance evaluation of Alfred60AST rapid susceptibility testing directly from positive blood cultures in the routine laboratory workflow.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2021, v. 40, n. 7, p. 1487, doi. 10.1007/s10096-021-04191-9
- By:
- Publication type:
- Article
Put the Vanc Down, Flip It and Reverse It: Comparison of Vancomycin and Daptomycin Health Care Utilization and Cost in Outpatient Parenteral Antimicrobial Therapy.
- Published in:
- Open Forum Infectious Diseases, 2024, v. 11, n. 8, p. 1, doi. 10.1093/ofid/ofae438
- By:
- Publication type:
- Article
Counting the Cost of Daptomycin Versus Vancomycin in Hospitalized Patients: A Cost Minimization Analysis.
- Published in:
- Open Forum Infectious Diseases, 2024, v. 11, n. 5, p. 1, doi. 10.1093/ofid/ofae217
- By:
- Publication type:
- Article
Pharmacovigilance Study on Eosinophilic Pneumonia Induced by Anti-MRSA Agents: Analysis Based on the FDA Adverse Event Reporting System.
- Published in:
- Open Forum Infectious Diseases, 2023, v. 10, n. 8, p. 1, doi. 10.1093/ofid/ofad414
- By:
- Publication type:
- Article
Seventeen Cases of Daptomycin-Induced Eosinophilic Pneumonia in a Cohort of Patients Treated for Bone and Joint Infections: Proposal for a New Algorithm.
- Published in:
- Open Forum Infectious Diseases, 2022, v. 9, n. 11, p. 1, doi. 10.1093/ofid/ofac577
- By:
- Publication type:
- Article
Clinical Profile of Monomicrobial Corynebacterium Hip and Knee Periprosthetic Joint Infections.
- Published in:
- Open Forum Infectious Diseases, 2022, v. 9, n. 7, p. 1, doi. 10.1093/ofid/ofac193
- By:
- Publication type:
- Article
Daptomycin-Resistant Enterococcus Bacteremia Is Associated With Prior Daptomycin Use and Increased Mortality After Liver Transplantation.
- Published in:
- Open Forum Infectious Diseases, 2022, v. 9, n. 3, p. 1, doi. 10.1093/ofid/ofab659
- By:
- Publication type:
- Article
Multicenter Cohort Study of Ceftaroline Versus Daptomycin for Treatment of Methicillin-Resistant Staphylococcus aureus Bloodstream Infection.
- Published in:
- Open Forum Infectious Diseases, 2022, v. 9, n. 3, p. 1, doi. 10.1093/ofid/ofab606
- By:
- Publication type:
- Article
Vancomycin or Daptomycin for Outpatient Parenteral Antibiotic Therapy: Does It Make a Difference in Patient Satisfaction?
- Published in:
- Open Forum Infectious Diseases, 2021, v. 8, n. 8, p. 1, doi. 10.1093/ofid/ofab418
- By:
- Publication type:
- Article
Clinical Outcomes With Definitive Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia With Retained Daptomycin and Ceftaroline Combination Therapy vs De-escalation to Monotherapy With Vancomycin, Daptomycin, or Ceftaroline.
- Published in:
- Open Forum Infectious Diseases, 2021, v. 8, n. 7, p. 1, doi. 10.1093/ofid/ofab327
- By:
- Publication type:
- Article
Clinical Trials Increase Off-Study Drug Use: A Segmented Time-Series Analysis.
- Published in:
- Open Forum Infectious Diseases, 2020, v. 7, n. 11, p. 1, doi. 10.1093/ofid/ofaa449
- By:
- Publication type:
- Article
Treatment of Staphylococcal Device Infections: Synergistic Daptomycin With Ceftaroline Versus Rifampin-Adjunct Therapy.
- Published in:
- Open Forum Infectious Diseases, 2020, v. 7, n. 3, p. N.PAG, doi. 10.1093/ofid/ofaa072
- By:
- Publication type:
- Article
1539. Dalbavancin, Vancomycin, and Daptomycin Alone and in Combination with Cefazolin Against Vancomycin Intermediate-Resistant (VISA) and Daptomycin Non-Susceptible (DNS) Staphylococcus aureus.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S561, doi. 10.1093/ofid/ofz360.1403
- By:
- Publication type:
- Article
596. Distinct, Segregated Daptomycin-Susceptible and Daptomycin-Nonsusceptible Staphylococcus aureus Populations Associated with Tricuspid-Valve Infective Endocarditis.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S280, doi. 10.1093/ofid/ofz360.665
- By:
- Publication type:
- Article
orally administered drug prevents selection for antibiotic-resistant bacteria in the gut during daptomycin therapy.
- Published in:
- Evolution, Medicine & Public Health, 2022, v. 10, n. 1, p. 439, doi. 10.1093/emph/eoac035
- By:
- Publication type:
- Article
Loss of daptomycin susceptibility in clinical Staphylococcus epidermidis infection coincided with variants in WalK.
- Published in:
- Evolution, Medicine & Public Health, 2020, v. 2020, n. 1, p. 219, doi. 10.1093/emph/eoaa031
- By:
- Publication type:
- Article
Oritavancin Versus Daptomycin for Osteomyelitis Treatment After Surgical Debridement.
- Published in:
- Infectious Diseases & Therapy, 2024, v. 13, n. 3, p. 535, doi. 10.1007/s40121-024-00925-2
- By:
- Publication type:
- Article
Targeting Dalbavancin Inoculum Effect: Adjunctive Single Dose of Daptomycin.
- Published in:
- Infectious Diseases & Therapy, 2023, v. 12, n. 10, p. 2485, doi. 10.1007/s40121-023-00875-1
- By:
- Publication type:
- Article
A Pharmacovigilance Analysis of Daptomycin Use Based on CLSI Susceptible Dose-Dependent Category.
- Published in:
- Infectious Diseases & Therapy, 2023, v. 12, n. 9, p. 2295, doi. 10.1007/s40121-023-00868-0
- By:
- Publication type:
- Article
The Combination of Daptomycin with Fosfomycin is More Effective than Daptomycin Alone in Reducing Mortality of Vancomycin-Resistant Enterococcal Bloodstream Infections: A Retrospective, Comparative Cohort Study.
- Published in:
- Infectious Diseases & Therapy, 2023, v. 12, n. 2, p. 589, doi. 10.1007/s40121-022-00754-1
- By:
- Publication type:
- Article
Comparative Efficacy and Safety of Vancomycin, Linezolid, Tedizolid, and Daptomycin in Treating Patients with Suspected or Proven Complicated Skin and Soft Tissue Infections: An Updated Network Meta-Analysis.
- Published in:
- Infectious Diseases & Therapy, 2021, v. 10, n. 3, p. 1531, doi. 10.1007/s40121-021-00456-0
- By:
- Publication type:
- Article
Using an Ordinal Approach to Compare Outcomes Between Vancomycin Versus Ceftaroline or Daptomycin in MRSA Bloodstream Infection.
- Published in:
- Infectious Diseases & Therapy, 2021, v. 10, n. 1, p. 605, doi. 10.1007/s40121-021-00401-1
- By:
- Publication type:
- Article
In Vitro Antimicrobial Activity of Fosfomycin, Vancomycin and Daptomycin Alone, and in Combination, Against Linezolid-Resistant Enterococcus faecalis.
- Published in:
- Infectious Diseases & Therapy, 2020, v. 9, n. 4, p. 927, doi. 10.1007/s40121-020-00342-1
- By:
- Publication type:
- Article
Monotherapy with Vancomycin or Daptomycin versus Combination Therapy with β-Lactams in the Treatment of Methicillin-Resistant Staphylococcus Aureus Bloodstream Infections: A Retrospective Cohort Analysis.
- Published in:
- Infectious Diseases & Therapy, 2020, v. 9, n. 2, p. 325, doi. 10.1007/s40121-020-00292-8
- By:
- Publication type:
- Article
Comparing the Outcomes of Ceftaroline Plus Vancomycin or Daptomycin Combination Therapy Versus Monotherapy in Adults with Complicated and Prolonged Methicillin-Resistant Staphylococcus Aureus Bacteremia Initially Treated with Supplemental Ceftaroline.
- Published in:
- Infectious Diseases & Therapy, 2020, v. 9, n. 1, p. 77, doi. 10.1007/s40121-019-00277-2
- By:
- Publication type:
- Article
Should High-dose Daptomycin be an Alternative Treatment Regimen for Enterococcal Endocarditis?
- Published in:
- Infectious Diseases & Therapy, 2019, v. 8, n. 4, p. 695, doi. 10.1007/s40121-019-00261-w
- By:
- Publication type:
- Article
Physiologically based pharmacokinetic modeling of daptomycin dose optimization in pediatric patients with renal impairment.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.838599
- By:
- Publication type:
- Article
Vancomycin, Daptomycin, Antistaphylococcal β-Lactam, and Trimethoprim-Sulfamethoxazole Monotherapy and Combination Therapy in the Management of Methicillin-Resistant Staphylococcus aureus : A Network Meta-Analysis.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.805966
- By:
- Publication type:
- Article
Uropathogens antibiotic susceptibility as an indicator for the empirical therapy used for urinary tract infections: a retrospective observational study.
- Published in:
- Iranian Journal of Microbiology, 2020, v. 12, n. 5, p. 395
- By:
- Publication type:
- Article
Data mining for adverse drug reaction signals of daptomycin based on real-world data: a disproportionality analysis of the US Food and Drug Administration adverse event reporting system.
- Published in:
- International Journal of Clinical Pharmacy, 2022, v. 44, n. 6, p. 1351, doi. 10.1007/s11096-022-01472-x
- By:
- Publication type:
- Article
Population Pharmacokinetic/Pharmacodynamic Modelling of Daptomycin for Schedule Optimization in Patients with Renal Impairment.
- Published in:
- Pharmaceutics, 2022, v. 14, n. 10, p. N.PAG, doi. 10.3390/pharmaceutics14102226
- By:
- Publication type:
- Article
Efficacy and Safety of Daptomycin versus Vancomycin for Bacteremia Caused by Methicillin-Resistant Staphylococcus aureus with Vancomycin Minimum Inhibitory Concentration > 1 µg/mL: A Systematic Review and Meta-Analysis.
- Published in:
- Pharmaceutics, 2022, v. 14, n. 4, p. N.PAG, doi. 10.3390/pharmaceutics14040714
- By:
- Publication type:
- Article
Implementation and Comparison of Two Pharmacometric Tools for Model-Based Therapeutic Drug Monitoring and Precision Dosing of Daptomycin.
- Published in:
- Pharmaceutics, 2022, v. 14, n. 1, p. 114, doi. 10.3390/pharmaceutics14010114
- By:
- Publication type:
- Article
Quantification of 15 Antibiotics Widely Used in the Critical Care Unit with a LC-MS/MS System: An Easy Method to Perform a Daily Therapeutic Drug Monitoring.
- Published in:
- Pharmaceuticals (14248247), 2021, v. 14, n. 12, p. 1214, doi. 10.3390/ph14121214
- By:
- Publication type:
- Article
Effect of Antibiotic Exposure on Staphylococcus epidermidis Responsible for Catheter-Related Bacteremia.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 2, p. 1547, doi. 10.3390/ijms24021547
- By:
- Publication type:
- Article
Treat Me Well or Will Resist: Uptake of Mobile Genetic Elements Determine the Resistome of Corynebacterium striatum.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 14, p. 7499, doi. 10.3390/ijms22147499
- By:
- Publication type:
- Article
The Antibiotic Peptide Daptomycin Functions by Reorganizing the Membrane.
- Published in:
- 2021
- By:
- Publication type:
- journal article
New-Generation Antibiotics for Treatment of Gram-Positive Infections: A Review with Focus on Endocarditis and Osteomyelitis.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 8, p. 1743, doi. 10.3390/jcm10081743
- By:
- Publication type:
- Article
Preanalytical Stability of 13 Antibiotics in Biological Samples: A Crucial Factor for Therapeutic Drug Monitoring.
- Published in:
- Antibiotics (2079-6382), 2024, v. 13, n. 7, p. 675, doi. 10.3390/antibiotics13070675
- By:
- Publication type:
- Article
Development and ELISA Characterization of Antibodies against the Colistin, Vancomycin, Daptomycin, and Meropenem: A Therapeutic Drug Monitoring Approach.
- Published in:
- Antibiotics (2079-6382), 2024, v. 13, n. 7, p. 600, doi. 10.3390/antibiotics13070600
- By:
- Publication type:
- Article
Daptomycin Use for Persistent Coagulase-Negative Staphylococcal Bacteremia in a Neonatal Intensive Care Unit.
- Published in:
- Antibiotics (2079-6382), 2024, v. 13, n. 3, p. 254, doi. 10.3390/antibiotics13030254
- By:
- Publication type:
- Article
In Vivo-Acquired Resistance to Daptomycin during Methicillin-Resistant Staphylococcus aureus Bacteremia.
- Published in:
- Antibiotics (2079-6382), 2023, v. 12, n. 12, p. 1647, doi. 10.3390/antibiotics12121647
- By:
- Publication type:
- Article
Daptomycin-Impregnated PMMA Cement against Vancomycin-Resistant Germs: Dosage, Handling, Elution, Mechanical Stability, and Effectiveness.
- Published in:
- Antibiotics (2079-6382), 2023, v. 12, n. 11, p. 1567, doi. 10.3390/antibiotics12111567
- By:
- Publication type:
- Article
Clinical Experience with Off-Label Intrathecal Administration of Selected Antibiotics in Adults: An Overview with Pharmacometric Considerations.
- Published in:
- Antibiotics (2079-6382), 2023, v. 12, n. 8, p. 1291, doi. 10.3390/antibiotics12081291
- By:
- Publication type:
- Article
Membrane Phenotypic, Metabolic and Genotypic Adaptations of Streptococcus oralis Strains Destined to Rapidly Develop Stable, High-Level Daptomycin Resistance during Daptomycin Exposures.
- Published in:
- Antibiotics (2079-6382), 2023, v. 12, n. 7, p. 1083, doi. 10.3390/antibiotics12071083
- By:
- Publication type:
- Article
Adaptive Laboratory Evolution of Staphylococcus aureus Resistance to Vancomycin and Daptomycin: Mutation Patterns and Cross-Resistance.
- Published in:
- Antibiotics (2079-6382), 2023, v. 12, n. 5, p. 928, doi. 10.3390/antibiotics12050928
- By:
- Publication type:
- Article
Daptomycin Pharmacokinetics in Blood and Wound Fluid in Critical Ill Patients with Left Ventricle Assist Devices.
- Published in:
- Antibiotics (2079-6382), 2023, v. 12, n. 5, p. 904, doi. 10.3390/antibiotics12050904
- By:
- Publication type:
- Article